688189

Hunan Nucien Pharmaceutical
688189

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥2.10B
EV
CN¥1.71B
Shares Outstanding
272.83M
Beta
0.23

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hunan Nucien Pharmaceutical Co., Ltd.

gainify
688189

Hunan Nucien Pharmaceutical Co., Ltd.

688189

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. It focuses on anti-influenza, cardiovascular, antibiotics, antipyretics, anti-allergy, pain relief, diabetes, cer...

Sector

Industry

CEO

Data Unavailable

Employees

366

IPO Date

Headquarters

Building 1-2, No. 196 Kaiyuan Avenue, Huangpu District, Guangzhou, Guangdong Province, 510100, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.